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The known increased need for iron during preg-
nancy, due to expansion of maternal red cell
volume and the requirements of the developing
fetus and placenta, appears to be met only in part
by increased iron absorption and amenorrhea [12].
For this reason, considerable demands must be
made on maternal iron stores, in particular in the
last trimester of pregnancy when iron requirement
rises to about 7 mg per day [10]. However, part of
the iron is only borrowed by the maternal red cell
mass and is largely returned after delivery.
Since available evidence suggests that a high
proportion of apparently healthy women of child-
bearing age lack sufficient storage iron [3], preg-
nancy may be expected to cause iron deficiency in
these women, which may also have a bearing on
the iron status of the fetus and neonate [9]. Based
on these considerations, prophylactic supplemen-
tation of dietary iron is advocated but remains a
disputed issue [2,5].
The present prospective and longitudinal study
was undertaken to investigate changes in
hematologic status, and in particular in iron stores,
during the course of pregnancy in healthy women
with and without oral iron supplements.
1 Patients and methods
The study involved 44 healthy Caucasian women
with a singleton pregnancy who attended the Ante-
natal Clinic of the University Hospital Dijkzigt,
Rotterdam. The women were selected on the basis
of a hemoglobin concentration of at least 7.0 mmol
per liter without iron supplementation at the time
of their first visit between 8 and 14 weeks of
amenorrhea.
After informed consent had been obtained, they
were randomly assigned to a study group in which
oral iron supplementation was given from the
16th week of amenorrhea until 6 weeks post
partum (n = 21), and a control group without iron
supplements (n = 23). The women in the study
group took one tablet of a sustained release pre-
paration of 525 mg of ferrosulfate* containing
105 mg of elemental iron daily at breakfast. They
were asked at each prenatal visit how many tablets
they had left and the women in the control group
were asked if they had started taking any medica-
tion.
Venous blood samples were collected in iron-free
containers in both groups at the start of the study
at 16 weeks gestation, at 28 and 36 weeks, at the
time of admission for delivery, and 6 and 12 weeks
post partum. A sample of venous cord blood was
collected immediately after delivery in all but
three cases. All samples were allowed to clot at
room temperature and the sera were stored at
— 20 °C until analysis.
All patients had uncomplicated pregnancies, and
were delivered vaginally of live healthy infants.
* FERO-GRADUMET (ABBOTT)
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Blood loss at delivery was less than 1000 ml in all
cases. Three women in the control group
developed anemia with a hemoglobin concentra-
tion below 6.5 mmol/L, and three women of the
study group decided to stop the iron supplemen-
tation for no obvious reason. These women were
omitted from the study.
Serum iron concentrations were determined
spectrophotometrically using the ferrozine reagent
[15]. Serum transferrin was measured by the single
radial immunodiffusion technique [15]. Serum
ferritin was estimated with a specific solid-phase
radioimmunoassay adopted from HALLIDAY et al.
[4]-
Since most variables did not show a GAUSSIAN
distribution, appropriate non-parametric tests
were used for statistical analysis, and 0.05 was
taken as the level of significance.
2 Results
The results of the measurements of the various
variables in matemal blood during the course of
gestation in women with and without iron supple-
mentation are summarized in Tab. I. There were
no significant differences at the beginning of the
study between women allocated to iron supple-
mentation and women in the control group with
regard to any of the variables studied.
Hemoglobin values in non-supplemented women
determined at 28 weeks of amenorrhea were
significantly reduced when compared to 16 weeks
(p < 0.05). After 28 weeks a gradual increase in
hemoglobin levels was observed, and at delivery
there was no statistical difference with the values
at 16 weeks. In iron supplemented women no
significant changes in hemoglobin concentrations
were observed.
Serum iron concentrations in untreated women
showed a significant (p<0.01) fall between 16
and 28 weeks of amenorrhea, and the concen-
trations remained at the same low level throughout
pregnancy. In the supplemented group serum iron
concentrations remained stable throughout preg-
nancy. No correlation between serum iron con-
centrations and hemoglobin levels could be
demonstrated. Serum transferrin levels rose in the
untreated as well as in the treated group. The
increase was significant between 16 and 28 weeks,
and between 28 and 36 weeks in both groups, but
more pronounced in non-supplemented women.
In both groups no significant correlation could be
demonstrated between transferrin levels and serum
iron, or hemoglobin concentrations.
The most marked changes occurred in the serum
ferritin concentrations, which showed important
variability between individuals in both groups. In
untreated women the mean ferritin concentrations
at 36 weeks were 30% and in iron supplemented
women 71% of the initial values at 16 weeks,
which means a significant fall in both groups. The
differences between serum ferritin concentrations
in treated and untreated women at 28 and
36 weeks, and at delivery, were highly significant
(p < 0.01). No significant correlations were found
between the concentrations of serum ferritin and
serum iron, transferrin or hemoglobin levels.
Tab. I. Iron status in uncomplicated singleton pregnancies with (upper values, n = 18) and without (lower values, n = 20)
oral iron supplements (means ± S.D.).
Hemoglobin
(mmol/L)
Serum iron
(Mmol/L)
Transferrin
(μιηοΙ/L)
Ferritin
(Mg/L)
16 weeks
8.0 ± 0.4
8.0 ± 0.5
23.0 ± 5.1
22.4 ± 6.5
90.4 ± 17.0
95.0 ± 21.4
74.5 ± 28.4
64.2 ± 38.0
28 weeks
7.8 ± 0.4
7.5 ± 0.4
25.8 ± 9.8
15.4 ± 4.7**
109.0 ± 21.0
125.2 ± 18.0*
66.4 ± 44.7
27.8 ±20.7**
36 weeks
7.8 ± 0.5
7.6 ± 0.6
22.9 ± 7.9
13.8 ± 5.9**
123.0 ± 17.7
131.7 ±20.2
52.8 ±32.0
19.2 ± 9.9**
At delivery
8.0 ± 0.7
7.8 ± 0.7
20.6 ± 11.4
14.0 ± 5.5*
122.7 ± 29.2
130.9 ±32.5
45.2 ± 22.9
23.9 ± 9.9**
6 weeks p. p.
8.5 ± 0.6
8.5 ± 0.6
19.8 ± 5.4
20.1 ± 7.2
89.8 ± 16.8
93.8 ± 16.4
67.7 ± 35.9
48.3 ± 26.2
12 weeks p.p.
8.8 ± 0.7
8.5 ± 0.5
19.5 ± 8.3
22.8 ± 5.8
94.7 ± 17.2
98.4 ± 23.9
65.5 ±42.1
37.8 ± 19.8*
* = p < 0.05 and ** = p < 0.01 between the study and the control group (WILCOXON rank-sum test, two-tailed).
J. Perinat. Med. 12 (1984)
Wallenburg, van Eijk, Iron supplementation
Tab. II. Iron status in venous cord blood in the iron
supplemented (n=17) and non-supplemented (n=18)
group (means ± S.D.)·
Hemoglobin (mmol/L)
Iron (μιηοΙ/L)
Transferrin (μπιοΙ/L)
Ferritin (Mg/L)
Non-supple-
mented
10.2 ± 0.7
32.5 ± 6.5
67.0 ± 10.3
208 ± 83.5
Supplemented
10.3 ± 1.0
30.3 ± 11.4
67.5 ±11.0
190 ±73.5
At six and 12 weeks post partum hemoglobin con-
centrations in both groups were significantly
higher than in early pregnancy and serum iron
concentrations were not significantly different
from those at 16 weeks of amenorrhea. Post
partum transferrin concentrations appeared to
have returned to early pregnancy levels in both
groups.
The ferritin concentration in serum at six and 12
weeks post partum was not different from that in
early pregnancy in iron supplemented women, but
it appeared to be still significantly lower in the
untreated group.
The values obtained in venous cord blood are
summarized in Tab. II. There were no significant
differences between both groups. No significant
correlations could be demonstrated between
variables of the maternal and fetal iron status in
iron supplemented women or in the control group.
3 Discussion
Physiologic changes during pregnancy have a
marked effect on the variables used to assess the
hematologic status. In pregnancy these variables
cannot be judged by reference to nonpregnant
standards. The relatively larger increase in plasma
volume as compared with red cell mass can be
calculated to cause a physiologic fall in hemo-
globin concentration of approximately 12% of
nonpregnant values in iron-sufficient pregnant
women. The lowest hemoglobin values can be
expected to occur around 34 weeks gestation,
when plasma expansion is maximal [10].
In the present study we found that hemoglobin
concentrations in non-supplemented pregnant
women at 36 weeks were 10% lower than the
levels determined six weeks post partum.
Assuming that the latter concentration reflects
nonpregnant values, the observed fall in hemo-
globin concentration can be fully explained by
physiologic hemodilution. Iron supplementation
appeared to prevent the physiologic fall in hemo-
globin concentration, presumably by elevating
erythrocyte volume [13]. Iron supplements also
prevented the decrease of serum iron concentra-
tion observed in non-supplemented pregnant
women. However, no correlation was found
between serum iron concentrations and hemoglobin
levels. The reasons for normal fluctuations in
serum iron are not understood, and serum iron
levels are known to be affected by recent ingestion
of iron [10].
It has been suggested that the rise in transferrin
concentrations, observed in our study as well as by
others [1], could be associated more closely with
rising estrogen levels than with changes in iron
status [6]. This concept is supported by the
absence of a significant correlation between hemo-
globin or serum iron concentrations and trans-
ferrin levels in our study, as well as by our finding
that iron supplements did not prevent the increase
in transferrin concentrations.
The concentration of ferritin in plasma or serum
has been shown to be a sensitive and accurate
indicator of mobilisable iron stores in nonpregnant
individuals [7, 14]. Data from the literature
suggest that a serum ferritin concentration of
1 μg/L represents 8 mg of storage iron [14]. How-
ever, it is not known how this data applies to preg-
nant women. The pregnant state might influence
the overflow of ferritin from organ stores into the
circulation and serum levels may be expected to
fall due to physiologic hemodilution.
In our study serum ferritin levels showed a wide
range of values. There was a gradual fall of serum
ferritin levels between 16 weeks and term in both
groups, but the decrease was significantly more
pronounced in women without iron supplements.
Even the 30% fall in ferritin levels in the supple-
mented group cannot be explained on the basis of
hemodilution alone. Therefore, accepting that in
pregnancy ferritin levels reflect, at least to some
extent, iron stores, this data indicates that iron is
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mobilized from the storage pool to meet the
increased demand during pregnancy. Considering
the fact that six and even 12 weeks after delivery
ferritin levels in non-supplemented women with-
out anemia were still significantly lower than in
the first trimester of pregnancy, whereas in supple-
mented women they had returned to early preg-
nancy values, we conclude that iron supplementa-
tion prevents depletion of iron stores during
pregnancy.
The relationship between the iron status of the
mother and that of the fetus is still controversial.
Like other investigators [8, 11] we found no
relationship between maternal and fetal variables
of the iron status, and in particular not between
maternal and fetal ferritin levels. There was no
difference in iron status between infants from
iron supplemented and from non-supplemented
women. Only KANESHIGE [9] reported a signifi-
cant correlation between maternal and fetal
ferritin levels at delivery. It should be realized that
our results, like those of other investigators, were
obtained in healthy, non-anemic women with a
reasonable amount of storage iron at the beginning
of pregnancy. We are not aware of studies on the
pathophysiologic effects of severe and long-
standing maternal iron depletion on the fetal
hematologic status.
The results of our study indicate that prophylactic
administration of iron raises hemoglobin levels
during pregnancy and prevents depletion of iron
stores. However, what is the actual benefit to the
patient? Controlled studies have failed to provide
evidence that the practicfe'of screening the hemo-
globin concentration of pregnant women at regular
intervals and treating them when anemia is
diagnosed, will have any adverse effect on the
course of pregnancy, or on maternal or fetal health
[5]. On the other hand, we found no correlation
between hemoglobin concentrations within the
normal range of values, and serum ferritin levels; a
normal hemoglobin concentration is a poor indica-
tor of iron stores. For this reason, the above
practice of screening for low hemoglobin levels
during pregnancy and treating only anemic
patients will leave many women with low iron
stores undetected and untreated. Our results show
that depleted iron stores are still found three
months after delivery. These women are at risk of
anemia, which will usually be diagnosed after
symptoms have appeared, since most women are
not screened on a regular basis between preg-
nancies.
On the basis of these considerations we favor
prophylactic iron supplementation in all pregnant
women, from the beginning of the second
trimester until delivery. Prescription of one tablet
daily of a sustained release preparation, like that
used in the present study, is well accepted by the
patients and causes hardly any gastrointestinal side
effects.
Summary
The known increased need for iron during pregnancy
appears to be met only in part by increased iron absorp-
tion and amenorrhea. Considerable demands are made
on maternal iron stores and, since many women lack
sufficient storage iron, pregnancy may be expected to
cause iron deficiency. This may lead to anemia in preg-
nancy and post partum and could also have a bearing on
the iron status of the fetus and the neonate. Based on
these considerations, prophylactic supplementation of
dietary iron is advocated but remains a disputed issue.
In the present controlled, prospective and longitudinal
study changes in hematologic status, and in particular in
iron stores, during pregnancy were investigated in
44 healthy Caucasian women with, uncomplicated preg-
nancies and deliveries. They were randomly assigned to
a study group (n = 21) receiving oral iron supplements
from the 16th week of amenorrhea until 6 weeks post
partum, and a control group (n = 23) without iron supple-
mentation. Maternal concentrations of hemoglobin, serum
iron, serum transferrin and serum ferritin were deter-
mined at 16, 28 and 36 weeks of amenorrhea, at delivery,
and 6 and 12 weeks post partum. The same variables
were determined in cord blood. Iron supplementation
appeared to prevent the physiologic fall in hemoglobin
and serum iron concentrations which occurred in the
control group, but had little influence on the observed
rise in transferrin concentrations. Ferritin levels in serum,
which are known to reflect mobilisable iron stores, fell to
30 % of the initial values in the control group and to 70 %
in the study group. Six and 12 weeks post partum ferritin
levels were still low in the nonsupplemented group
(Tab. I). No differences were found between the
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hematologic variables in venous cord blood from infants
from supplemented and nonsupplemented women
(Tab. II). No correlations were found between the various
variables of the maternal hematologic status, in particular
not between hemoglobin concentrations and ferritin
levels; a normal hemoglobin concentration appears to be a
poor indicator of iron stores. We found no relationship
between maternal and fetal iron status. Our study shows
that depleted iron stores are still found three months
following pregnancy without iron supplementation.
To prevent depletion of iron stores during pregnancy we
favor prophylactic iron supplementation in all pregnant
women from the beginning of the second trimester until
delivery.
Keywords: Ferritin, hematologic status, hemoglobin, iron supplementation, serum iron, transferrin.
Zusammenfassung
Einfluß einer oralen Eisengabe auf den mütterlichen und
fetalen Eisenhaushalt während der Schwangerschaft
Der bekannte erhöhte Eisenbedarf während der Schwan-
gerschaft kann wahrscheinlich nur zum Teil durch eine
gesteigerte Eisenresorption sowie die Amenorrhoe kom-
pensiert werden. Die mütterlichen Eisenspeicher werden
in hohem Maße beansprucht; da viele Frauen ungenügende
Eisenreserven haben, kann man erwarten, daß die
Schwangerschaft einen Eisenmangel verursacht. Dies führt
zu einer Anämie in der Schwangerschaft sowie post
partum und könnte auch Auswirkungen auf den Eisen-
haushalt des Feten bzw. Neugeborenen haben. Auf der
Grundlage dieser Überlegungen wird zwar zu einer
prophylaktischen oralen Eisengabe geraten, sie ist jedoch
nicht unumstritten. In der vorliegenden kontrollierten,
prospektiven Longitudinalstudie untersuchten wir Ver-
änderungen des hämatologischen Status und speziell der
Eisenspeicher bei 44 gesunden Frauen der kaukasischen
Rasse mit unkomplizierter Schwangerschaft und Geburt.
Nach dem Zufallsprinzip bildeten wir ein Kollektiv
(n = 21), das orale Eisengaben von der 16. Woche nach
Beginn der Amenorrhoe bis zur 6. Woche post partum
erhielt, sowie eine Kontrollgruppe (n = 23) ohne jede
Eisenmedikation. Wir bestimmten die mütterlichen Kon-
zentrationen von Hämoglobin, Serumeisen, Sem m trans-
ferrin und Serumferritin in der 16., 28. und 36. Woche
nach Beginn der Amenorrhoe, bei der Geburt sowie 6
bzw. 12 Wochen post partum. Die gleichen Parameter
wurden im Nabelschnurblut gemessen. Die Eisengabe
scheint den physiologischen Abfall der Hämoglobin-
und Eisenspiegel, der in der Kontrollgruppe erfolgte,
zu verhindern; sie hatte aber wenig Einfluß auf den
beobachteten Anstieg der Transferrinkonzentration. Die
Ferritinspiegel im Serum, die bekanntlich ein Maß für die
mobilisierbaren Eisenspeicher darstellen, fielen auf 30%
der Ausgangswerte in der Kontrollgruppe bzw. auf 70 %
der Ausgangswerte in dem behandelten Kollektiv zurück.
6 bzw. 12 Wochen post partum waren in der unbehandel-
ten Gruppe die Ferritinspiegel immer noch niedrig
(Tab.I). Bezüglich der hämatologischen Parameter im
venösen Nabelschnurblut fanden sich keine singifikanten
Unterschiede zwischen den Kindern behandelter bzw.
unbehandelter Frauen (Tab. II). Die Variablen im mütter-
lichen hämatologischen Status, speziell die Hämoglobin-
konzentration und der Ferritinspiegel veränderten sich
nicht in Korrelation zueinander; ein normaler Hämo-
globinwert läßt kaum eine Aussage über die Eisenspeicher
zu. Wir fanden keine Zusammenhänge zwischen dem
mütterlichen und fetalen Eisenhaushalt. Unsere Studie
zeigt, daß. noch 3 Monate nach der Schwangerschaft
erschöpfte Eisenvorräte bei Frauen ohne Eisenmedika-
tion gefunden werden. Um eine Entleerung der Eisen-
speicher während der Schwangerschaft zu verhindern,
empfehlen wir eine prophylaktische Eisengabe an alle
schwangeren Frauen vom Beginn des zweiten Trimesters
bis zur Entbindung.
Schlüsselwörter: Eisengabe, Ferritin, hämatologischer Status, Hämoglobin, Serumeisen, Transferrin.
Resume
Effet sur Fequilibre martial de la mere et du foetus d'une
supplementation orale en cours de grossesse
On connait le besoin accru en fer au cours de la grossesse;
il semble n'etre couvert que partiellement par Taugmenta-
tion de l'absorbtion martiale et par l'amenorrhee. Les
reserves martiales maternelles sont utüisees de faqon
considerable, et, puisque de nombreuses femmes n'ont
pas de reserves süffisantes, on peut s'attendre ä ce quela
grossesse soit responsable de carence martiale. Celle-ci
peut conduire ä une anemie de la grossesse ou du post-
partum et peut egalement retentir sur l'equilibre martial
du foetus ou du nouveau-ne. On preconise une supplemen-
tation prophylactique du fer alimentaire, fondee sur ces
considerations, mais son interet demeure controverse.
Dans cette etude contrölee, prospective et longitudinale,
on a explore au cours de la grossesse, chez 44 femmes
caucasiennes en bonne sante sans complication gravidique
ni lors de l'accouchement, les modifications de Pequi-
libre hematologique, et particuiierement les reserves
martiales. Ces femmes ont ete apariees par randomisation
ä un groupe (n = 21) recevant une supplementation orale
en fer, de la 16eme semaine d'amenorrhee ä la 6eme
semaine du post-partum, et ä un groupe controle (n = 23)
sans supplementation en fer. On a determine les concen-
trations maternelles d'hemoglobine, de fer serique et de
ferritine ä 16,28 et a 36 semaines d'amenorrhee, ä
l'accouchement, ainsi qu'ä 6 et 12 semaines apres l'accou-
chement. Les memes parametres ont ete mesures sur le
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sang du cordon. II apparait qu'une supplementation en fer
previent la chute physiologique de l'hemoglobine et du
fer serique qui survient dans le groupe tempin, mais
qu'elle n'a qu'une petite influence sur 1'elevation observee
de la concentration de transferrine. Les taux seriques
de ferritine qui sont connus pour refleter les reserves de
fer mobilisable chutent 30 % des valeurs initiales dans
le groupe temoin et 70 % dans le groupe etudie. Dans le
groupe sans supplementation, les taux de ferritine sont
encore bas 6 a 12 semaines apres 1'accouchement
(Tab. I). On n'a pas tronve de differences au niveau des
parametres hematologiques du sang du cordon entre les
enfants de meres avec et sans supplementation (Tab. II).
On n'a pas trouve de correlation entre les differentes
variables de 1'etat hematologique maternel, en parti-
culier entre la concentration d'hemoglobine et les taux
de ferritine; une concentration normale en hemoglobine
est un mauvais indicateur d6a reserves martiales. Nous
n'avons pas trouve de relation entre Pequilibre martial
de la mere et du foetus. Notre etude montre qu'une
depletion des reserves martiales se retro ve encore trois
mois apres la grossesse lorsqu'il n'y a pas de supplemen-
tation en fer. Nous sommes pour une supplementation
prophylactique en fer afin de prevenir une depletion des
reserves martiales au couis de la grossesse, chez toutes les
femmes enceintes du debut du second trimestre jusqu'
1'accouchement.
Mots-cles: Equilibre hematologique, ferritine, fer serique, hemoglobine, supplementation en fer, transferrine.
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